Trade MIRM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Mirum Pharmaceuticals, Inc. (MIRM) is trading at US$86.01, up 5.73% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$5.87B. Over the past 52 weeks, MIRM has traded between US$63.23 and US$130.00. On Syfe you can trade MIRM with $0 commission and add it to your watchlist.
| Previous close | US$81.35 |
|---|---|
| Market cap | US$5.87B |
| 52-week range | US$63.23 – US$130.00 |
| Volume | 1.14M |
| Exchange | US |
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Year: 2019
Mirum Pharmaceuticals Insider Sold Shares Worth $4,000,000, According to a Recent SEC Filing
Aug 20, 7:54 AM · MT Newswires
Mirum Pharmaceuticals Insider Sold Shares Worth $1,978,402, According to a Recent SEC Filing
Aug 11, 9:49 PM · MT Newswires
RBC Capital Adjusts Mirum Pharmaceuticals PT to $135 From $148, Maintains Outperform Rating
Aug 6, 12:59 PM · MT Newswires
Mirum Pharmaceuticals, Inc. (MIRM) stock is trading at US$86.01, +5.73% from the previous close of US$81.35.
The market cap for Mirum Pharmaceuticals, Inc. (MIRM) stock is approximately US$5.87B.
The 52-week high for Mirum Pharmaceuticals, Inc. (MIRM) stock is US$130.00.
The 52-week low for Mirum Pharmaceuticals, Inc. (MIRM) stock is US$63.23.
Mirum Pharmaceuticals, Inc. (MIRM) does not currently pay a dividend.
Stay on top of MIRM
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
